2011, J. Biomed. Mater. Res. A, 98A, 7, 10.1002/jbm.a.33084
2011, J. Mater. Sci. Mater. Med., 22, 2053, 10.1007/s10856-011-4381-9
2007, Biomaterials, 28, 3074, 10.1016/j.biomaterials.2007.03.013
2003, J. Biomed. Mater. Res. A, 65A, 319, 10.1002/jbm.a.10371
2014, Biointerphases, 9, 029017, 10.1116/1.4878719
2010, Biomaterials, 31, 832, 10.1016/j.biomaterials.2009.10.008
2012, Langmuir, 28, 2745, 10.1021/la204777x
1998, Annu. Rev. Biochem., 67, 395, 10.1146/annurev.biochem.67.1.395
2008, Arterioscler., Thromb., Vasc. Biol., 28, 403, 10.1161/ATVBAHA.107.150474
1995, J. Biol. Chem., 270, 5077, 10.1074/jbc.270.10.5077
2007, Thromb. Haemostasis, 98, 283, 10.1160/TH07-03-0163
2006, Phys. Rev. Lett., 97, 138101, 10.1103/PhysRevLett.97.138101
2007, Proc. Natl. Acad. Sci. U. S. A., 104, 7899, 10.1073/pnas.0608422104
1996, Biomaterials, 17, 1279, 10.1016/S0142-9612(96)80004-4
1998, Biomaterials, 19, 251, 10.1016/S0142-9612(97)00206-8
2005, Semin. Thromb. Hemostasis, 31, 381, 10.1055/s-2005-916671
2007, Biomaterials, 28, 5144, 10.1016/j.biomaterials.2007.07.035
2013, Clin. Hemorheol. Microcirc., 53, 71, 10.3233/CH-2012-1577
2013, Clin. Hemorheol. Microcirc., 53, 97, 10.3233/CH-2012-1579
2013, Biointerphases, 8, 33, 10.1186/1559-4106-8-33
1986, Blood–Surface Interactions: Biological Principles Underlying Haemocompatibility with Artificial Materials
Colman, 1994, Interaction of blood with artificial surfaces, Hemostasis and Thrombosis, Basic Principles and Clinical Practice, 1469
2015, Clin. Hemorheol. Microcirc., 60, 133, 10.3233/CH-151942
2006, Blood, 107, 3537, 10.1182/blood-2005-02-0618
2002, Proc. Natl. Acad. Sci. U. S. A., 99, 425, 10.1073/pnas.012459599
2001, J. Biomed. Mater. Res., 58, 467, 10.1002/jbm.1043
2008, Biomaterials, 28, 5028, 10.1016/j.biomaterials.2007.07.048
2006, J. Am. Coll. Cardiol., 48, 193, 10.1016/j.jacc.2006.03.042
1969, J. Biomed. Mater. Res., 3, 191, 10.1002/jbm.820030115
1980, J. Membr. Biol., 57, 87, 10.1007/BF01868994
2011, Acta Biomater., 7, 3692, 10.1016/j.actbio.2011.06.007
1990, Blood Coagulation Fibrinolysis, 1, 543, 10.1097/00001721-199010000-00035
1991, Complement Inflammation, 8, 61, 10.1159/000463181
1995, Biomaterials, 16, 1305, 10.1016/0142-9612(95)91045-Z
2000, Biomaterials, 21, 2059, 10.1016/S0142-9612(00)00099-5
2007, Biomaterials, 28, 5044, 10.1016/j.biomaterials.2007.06.035
2015, Biomaterials, 71, 145, 10.1016/j.biomaterials.2015.08.039
2014, Int. J. Cardiol., 177, 461, 10.1016/j.ijcard.2014.09.105
2010, MRS Bull., 35, 607, 10.1557/mrs2010.529
National Heart, Lung and Blood Institute (U.S.) NI of H, 1985, Guidelines for Blood–Material Interactions: Report of the National Heart, Lung, and Blood Insitute Working Group
National Heart, Lung and Blood Institute (U.S.) NI of H, 1980, Guidelines for Physicochemical Characterization of Biomaterials
1992, The Reference Materials of the European Communities: Results of Hemocompatibility Tests
Scientifica (Cairo), 2013, 392584, 10.1155/2013/392584
2009, J. Biomed. Mater. Res. A, 89A, 951, 10.1002/jbm.a.32034
2015, Biomaterials, 36, 55, 10.1016/j.biomaterials.2014.09.011
2010, Anticoagulants, Antiplatelets, and Thrombolytics, 2nd ed.
2011, Crit. Care, 15, 202, 10.1186/cc9358
2014, Clin. Kidney J., 8, 31, 10.1093/ckj/sfu127
